EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology of adult t-cell leukemia/lymphoma in people living with HTLV-1: A 30-year study in Peru

Gabriela Garrido-Pinzás iD, Brian Valenzuela, Elsa González-Lagos, Carlos Seas, Luis Malpica, Carolina Álvarez, Victor Rivera, Fernando Mejía, Martín Montes, Juan Carlos Ramos, Eduardo Gotuzzo iD

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0014010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Gabriela Garrido-Pinzás und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Human T-lymphotropic virus 1, HTLV-I Infections. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adult T-cell Leukemia/Lymphoma (ATL) is caused by human T-leukemia virus type 1 (HTLV-1). Over 10 million people are infected worldwide, but only up to 5% develop ATL. HTLV-1 infection is endemic in Peru; however, there are currently no reports focusing on the epidemiological characteristics of Peruvian individuals with ATL.

Methods

Data from the HTLV-1 Unit registry was retrospectively analyzed between June 1992 and November 2023. Clinical report forms and histopathology records from national referral cancer centers were reviewed. Descriptive statistics were used to characterize patients, and Kaplan-Meier methods assessed survival by ATL subtype.

Findings

A total of 116 confirmed ATL cases were identified. There was a slight female predominance, with 52.6% women (n = 61) and 47.4% men (n = 55). The median age at diagnosis was 54 years (IQR 42–61), with 42.2% of patients diagnosed before age 50. Only 13.8% of patients (n = 16) were diagnosed with HTLV-1 infection before ATL development, and only 8 of those were diagnosed through routine screening. The most common ATL subtype was lymphomatous (65.5%), followed by smoldering/chronic (24.1%), and acute ATL (9.5%). With a median follow-up of 15.9 months, median survival times were 6.5, 12.5, and 89.6 months for acute, lymphomatous, and smoldering/chronic subtypes, respectively. One-year survival rates ranged from 37.5% in acute ATL to 84.6% in smoldering/chronic ATL. Comorbid HTLV-1-associated diseases included infective dermatitis (15.5%), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (8.6%), and Strongyloides stercoralis hyperinfection (6.9%).

Interpretation

This is the first study to describe ATL epidemiology in Peru from an infectious disease perspective. Most patients were unaware of their HTLV-1 status before developing ATL, highlighting missed opportunities for earlier detection. Routine HTLV-1 testing should be considered in the evaluation of T-cell malignancies in endemic countries. In addition, screening high-risk populations could support earlier diagnosis and reduce transmission. Improving access to diagnostic tools, along with stronger collaboration between infectious diseases and oncology services could improve patient outcomes in endemic regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia-Lymphoma, Adult T-CellHuman T-lymphotropic virus 1HTLV-I InfectionsHumansPeruFemaleMiddle AgedAdultMaleRetrospective StudiesAged

Autor:innen und Institutionen

  • Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Department of Infectious, Tropical and Dermatological Diseases, Hospital Cayetano Heredia, Lima, Peru.
  • Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Department of Hemato-Oncology, Hospital Cayetano Heredia, Lima, Peru.
  • Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, United States of America.

ORCID-Profile: Gabriela Garrido-Pinzás, Eduardo Gotuzzo

Zitieren

APA

Garrido-Pinzás, G., Valenzuela, B., González-Lagos, E., Seas, C., Malpica, L., Álvarez, C., Rivera, V., Mejía, F., Montes, M., Ramos, J. C., & Gotuzzo, E. (2026). Epidemiology of adult t-cell leukemia/lymphoma in people living with HTLV-1: A 30-year study in Peru. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014010

Vancouver

Garrido-Pinzás G, Valenzuela B, González-Lagos E, Seas C, Malpica L, Álvarez C, et al. Epidemiology of adult t-cell leukemia/lymphoma in people living with HTLV-1: A 30-year study in Peru. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014010

BibTeX
@article{GarridoPinzs2026,
  author = {Garrido-Pinzás, Gabriela and Valenzuela, Brian and González-Lagos, Elsa and Seas, Carlos and Malpica, Luis and Álvarez, Carolina and Rivera, Victor and Mejía, Fernando and Montes, Martín and Ramos, Juan Carlos and Gotuzzo, Eduardo},
  title = {Epidemiology of adult t-cell leukemia/lymphoma in people living with HTLV-1: A 30-year study in Peru},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0014010}
}
Kostenlos starten →